Lamin A/C antibody | knockout validation | Santa Cruz sc-376248

This is a knockout-validated antibody summary, based on the publication "Activation of PDGF pathway links LMNA mutation to dilated cardiomyopathy", as cited below [1]. Labome curates formal publications to compile a list of antibodies with unambiguous specificity within Validated Antibody Database (VAD).

Antibody information

Mouse monoclonal IgG1 (kappa light chain)

Company: Santa Cruz

Antibody: Lamin A/C

Catalog number: sc-376248

Summary: Mouse monoclonal IgG1 (kappa light chain) specific for an epitope mapping between amino acids 2-29 at the N-terminus of human Lamin A/C. Recommended for detection of Lamin A and Lamin C of mouse, rat and human origin by western blot, immunoprecipitation, immunofluorescence, immunohistochemistry (paraffin) and ELISA. Also reactive with additional species, including equine, canine, bovine and porcine.

Validation Method

Western blot

Sample

Control and mutant induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs).

Blocking agent

Membrane Blocking Solution (Life Technologies).

Primary incubation

Overnight at 4 °C.

Secondary incubation

Appropriate secondary antibodies for 1 h at room temperature.

Detection

ECL Western Blotting Analysis System (GE Healthcare).

Figure

Immunoblot analysis of the levels of lamin A/C in control and mutant iPSC-CMs. The anti-LMNA (E-1) antibody was used (lot C1413). GAPDH and α-tubulin are used as loading controls. Please see Figure 3b in the article [1].

References
  1. Lee J, Termglinchan V, Diecke S, Itzhaki I, Lam C, Garg P, et al. Activation of PDGF pathway links LMNA mutation to dilated cardiomyopathy. Nature. 2019;572:335-340 pubmed publisher